Cargando…
DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways
DBF4-dependent kinase (DDK) is a two-subunit kinase required for initiating DNA replication at individual origins and is composed of CDC7 kinase and its regulatory subunit DBF4. Both subunits are highly expressed in many diverse tumor cell lines and primary tumors, and this is correlated with poor p...
Autores principales: | Sasi, Nanda Kumar, Bhutkar, Arjun, Lanning, Nathan J., MacKeigan, Jeffrey P., Weinreich, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406526/ https://www.ncbi.nlm.nih.gov/pubmed/28448802 http://dx.doi.org/10.1016/j.neo.2017.03.001 |
Ejemplares similares
-
DDK Has a Primary Role in Processing Stalled Replication Forks to Initiate Downstream Checkpoint Signaling
por: Sasi, Nanda Kumar, et al.
Publicado: (2018) -
The Potent Cdc7-Dbf4 (DDK) Kinase Inhibitor XL413 Has Limited Activity in Many Cancer Cell Lines and Discovery of Potential New DDK Inhibitor Scaffolds
por: Sasi, Nanda Kumar, et al.
Publicado: (2014) -
Downregulation of the Mitochondrial Phosphatase PTPMT1 Is Sufficient to Promote Cancer Cell Death
por: Niemi, Natalie M., et al.
Publicado: (2013) -
Mitochondria in cancer: at the crossroads of life and death
por: Fogg, Vanessa C., et al.
Publicado: (2011) -
Unique Metabolic Contexts Sensitize Cancer Cells and Discriminate between Glycolytic Tumor Types
por: Chacon-Barahona, Jonathan A., et al.
Publicado: (2023)